You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VRTX Sale Disclosure
Kewalramani Reshma · SEC Form 4 · Filed Nov 10, 2026
Sale
Calculated transaction value
$6.31M
Kewalramani Reshma CEO & President
VRTX
Transaction date
Nov 6, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 4 days later
VRTX daily price context
Close on/before transaction
$547.09
Nov 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,866 shares @ $531.53
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000875320-26-000293
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$6.31M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma VRTX Current | Sale | Nov 6, 2026 | $6.31M |